ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
15 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
1.6K
|
464K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
2 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.6K
|
464K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
2 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.6K
|
464K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
1 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.6K
|
464K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
9 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.6K
|
464K
|
9
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Corporate Presentation May 2021
|
|
RickyH
|
6 |
4.4K |
0 |
06/06/21 |
06/06/21 |
ASX - By Stock
|
6
|
4.4K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
RickyH
|
300 |
86K |
0 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
300
|
86K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
RickyH
|
300 |
86K |
0 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
300
|
86K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
RickyH
|
300 |
86K |
3 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
300
|
86K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
5 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
1.6K
|
464K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
27 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
1.6K
|
464K
|
27
|
|
ASX - By Stock
|
AVH |
Re:
Listen to this
|
|
RickyH
|
80 |
29K |
5 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
80
|
29K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
3 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
1.0K
|
418K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
3 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
RickyH
|
115 |
35K |
11 |
22/05/21 |
22/05/21 |
ASX - By Stock
|
115
|
35K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast - all set to boom
|
|
RickyH
|
243 |
90K |
5 |
15/05/21 |
15/05/21 |
ASX - By Stock
|
243
|
90K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
3 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
4 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
10 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
1 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
40 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
RickyH
|
1.6K |
464K |
3 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
1.6K
|
464K
|
3
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
RickyH
|
533 |
191K |
7 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
533
|
191K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
3 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
RickyH
|
165 |
39K |
8 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
165
|
39K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
RickyH
|
165 |
39K |
4 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
165
|
39K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
0 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
RickyH
|
165 |
39K |
12 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
165
|
39K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
RickyH
|
422 |
145K |
3 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
422
|
145K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RickyH
|
17K |
6.7M |
5 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RickyH
|
17K |
6.7M |
3 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RickyH
|
17K |
6.7M |
9 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
RickyH
|
422 |
145K |
3 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
422
|
145K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
RickyH
|
429 |
130K |
5 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
429
|
130K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
RickyH
|
422 |
145K |
9 |
07/03/21 |
07/03/21 |
ASX - By Stock
|
422
|
145K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
RickyH
|
508 |
172K |
0 |
07/03/21 |
07/03/21 |
ASX - By Stock
|
508
|
172K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
RickyH
|
508 |
172K |
5 |
07/03/21 |
07/03/21 |
ASX - By Stock
|
508
|
172K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
RickyH
|
508 |
172K |
13 |
06/03/21 |
06/03/21 |
ASX - By Stock
|
508
|
172K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
RickyH
|
422 |
145K |
5 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
145K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Pale Ale
|
|
RickyH
|
21 |
7.4K |
3 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
21
|
7.4K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
RickyH
|
423 |
126K |
1 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
423
|
126K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
RickyH
|
905 |
286K |
10 |
20/02/21 |
20/02/21 |
ASX - By Stock
|
905
|
286K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
RickyH
|
423 |
126K |
4 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
423
|
126K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
RickyH
|
175 |
41K |
12 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
175
|
41K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
RickyH
|
423 |
126K |
30 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
423
|
126K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
RickyH
|
1.1K |
314K |
6 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
RickyH
|
1.1K |
314K |
2 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
RickyH
|
1.1K |
314K |
16 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
RickyH
|
1.1K |
314K |
8 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
RickyH
|
1.1K |
314K |
5 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
5
|
|